Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 330.85 INR 0.33% Market Closed
Market Cap: 30.5B INR
Have any thoughts about
Indoco Remedies Ltd?
Write Note

Indoco Remedies Ltd
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Indoco Remedies Ltd
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Indoco Remedies Ltd
NSE:INDOCO
Other Current Assets
â‚ą322.4m
CAGR 3-Years
-35%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Other Current Assets
â‚ą25.3B
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Other Current Assets
â‚ą10.8B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
31%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Other Current Assets
â‚ą23.9B
CAGR 3-Years
6%
CAGR 5-Years
-2%
CAGR 10-Years
-1%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Other Current Assets
â‚ą3.4B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
1%
M
Mankind Pharma Ltd
NSE:MANKIND
Other Current Assets
â‚ą6.6B
CAGR 3-Years
68%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Indoco Remedies Ltd
Glance View

Market Cap
30.5B INR
Industry
Pharmaceuticals

Indoco Remedies Ltd. engages in manufacturing and marketing of Formulations (Finished Dosage Forms) and active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-01-07. The firm is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The firm's geographical segments include India and Outside India. The firm has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.

INDOCO Intrinsic Value
409.51 INR
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Indoco Remedies Ltd's Other Current Assets?
Other Current Assets
322.4m INR

Based on the financial report for Mar 31, 2024, Indoco Remedies Ltd's Other Current Assets amounts to 322.4m INR.

What is Indoco Remedies Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
-23%

Over the last year, the Other Current Assets growth was 89%. The average annual Other Current Assets growth rates for Indoco Remedies Ltd have been -35% over the past three years , -23% over the past five years .

Back to Top